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in healthy subjects – A systematic
review of modifiers. Considerations
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Abstract
Quantitative measurements of brain perfusion are influenced by perfusion-modifiers. Standardization of measurement
conditions and correction for important modifiers is essential to improve accuracy and to facilitate the interpretation of
perfusion-derived parameters. An extensive literature search was carried out for factors influencing quantitative meas-
urements of perfusion in the human brain unrelated to medication use. A total of 58 perfusion modifiers were categor-
ized into four groups. Several factors (e.g., caffeine, aging, and blood gases) were found to induce a considerable effect on
brain perfusion that was consistent across different studies; for other factors, the modifying effect was found to be
debatable, due to contradictory results or lack of evidence. Using the results of this review, we propose a standard
operating procedure, based on practices already implemented in several research centers. Also, a theory of ‘deep MRI
physiotyping’ is inferred from the combined knowledge of factors influencing brain perfusion as a strategy to reduce
variance by taking both personal information and the presence or absence of perfusion modifiers into account. We
hypothesize that this will allow to personalize the concept of normality, as well as to reach more rigorous and earlier
diagnoses of brain disorders.
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Introduction
Brain perfusion is essential for the delivery of oxygen
and glucose to the brain, and is tightly coupled with
brain metabolism and function.1 However, brain perfu-
sion is also aﬀected by numerous factors not related to
brain metabolism, such as blood gasses, hematocrit and
caﬀeine. This confounds the interpretation of brain per-
fusion measurements, due to a large between- and
within-subject variability (16.2% and 4.8%, respect-
ively).2 The quantiﬁcation of the micro-vascular cere-
bral perfusion and its strongly related macro-vascular
component cerebral blood ﬂow (CBF) can be per-
formed with several imaging methods (summarized in
Table 1), such as: 133Xenon inhalation and injection
technique, N2O inhalation technique (Kety Schmidt
technique), single photon emission computed tomog-
raphy (SPECT), positron emission tomography
(PET), transcranial Doppler (TCD) sonography and
magnetic resonance imaging (MRI) using dynamic sus-
ceptibility contrast (DSC) or arterial spin labeling
(ASL).1,3 ASL utilizes magnetically labeled water as
an endogenous tracer, obviating the need for both
ionizing radiation and intravenous contrast bolus injec-
tion, which makes it the least invasive and cheapest
technique to measure whole-brain and regional paren-
chymal perfusion.3 Thus, ASL has the potential to be a
widely available perfusion technique in the quest for
viable biomarkers of brain health and disease.1 One
of the most promising applications of ASL is in
the diagnosis of neurodegenerative conditions.1
A multimodal approach including ASL can also be
applied to pathophysiological research, clinical diagno-
sis, and evaluation of novel therapies in psychiatric
disorders.1
Regional distribution of cerebral perfusion and pat-
tern recognition on perfusion maps may oﬀer a
major contribution to understand pathophysiological
abnormalities,4 but pathology at very early stages
might be confounded by large individual variations in
perfusion due to physiology,5 aspects of lifestyle,6–8
dietary habits,9 and medication use.10,11 Alternatively,
physiological variations at the individual level can be
mistaken as abnormalities when not properly taken
into account. Unwanted variations of perfusion
should be small compared to disease-related alterations
if ASL-based perfusion measurements are to be used in
individual patients. Researchers have tried to map the
impact of many factors that modify cerebral perfusion
and to investigate its complexity for decades. Given
that ASL is increasingly being used in large population
studies and in clinical radiology, the accuracy of perfu-
sion measurements has gained a new relevance and
hence the understanding of physiological variability is
extremely important. The aim of this review is to sys-
tematically assess the magnitude of global and regional
eﬀects of perfusion-modiﬁers and to gain insight into
the current level of knowledge represented by the litera-
ture. In this review, a perfusion modiﬁer is deﬁned as
any normal physiological variation that gives rise to a
change in cerebral perfusion. From this synthesis, sev-
eral possible practical solutions are proposed to
increase the precision of perfusion quantiﬁcation.
Materials and methods
A comprehensive literature search for studies published
between 1952 and August 2016 was carried out using
the Web of Science and PubMed databases. First, an
exploration of all possible terms related to cerebral per-
fusion modiﬁers was performed. Subsequently, those
terms (e.g. caﬀeine, nicotine, age and gender) were
used to further reﬁne the search in combination with
the terms: ‘cerebral blood ﬂow’ and ‘cerebral perfu-
sion’. Articles were selected on the basis of two main
criteria: characteristics of the included subjects, and the
applied techniques. Only English, original research full-
text articles using non-anaesthetized healthy adults
were included. For the modiﬁer, ‘age – children’ studies
including non-anaesthetized healthy children were
also considered. The applied techniques to investigate
cerebral perfusion and blood ﬂow are summarized in
Table 1. Studies investigating the eﬀects of prescribed
medicinal drugs on cerebral perfusion were excluded.
The modiﬁers were divided into four groups:
(1) physiology, lifestyle and health; (2) blood
Table 1. Techniques applied to measure cerebral perfusion and
blood flow on microvascular and macrovascular level.
Microvascular level: Cerebral perfusion
133Xe inhalation/intravenous injection techniques
85Kr inhalation/intravenous injection technique
N20 inhalation (Kety Schmidt technique)
Single-photon emission computed tomography (SPECT),
tracers:
# 133Xe
# N-isopropyl-[123I] p-iodoamphetamine (123IMP)
# Technetium exametazime (99mTc-HMPAO)
# Technetium ethyl cysteinate dimer (99mTc-ECD)
Positron emission tomography (PET), tracers:
# 15O-H2O
# 15O-CO2
Perfusion-weighted magnetic resonance imaging (PW-MRI):
# Dynamic susceptibility contrast (DSC) MR perfusion
# Dynamic contrast enhanced (DCE) MR perfusion
# Arterial spin labeling
Macrovascular level: Cerebral blood flow
Transcranial Doppler ultrasound (TCD)
Angiography X-ray
Phase-contrast/angiography MRI
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components; (3) mental state, personality and cogni-
tion; and (4) caﬀeine and recreational drugs (Table 2).
All full-text articles found were scrutinized. For each
modiﬁer, three modiﬁer criteria were calculated. First, a
consistency score was calculated based on the main
eﬀect of the modiﬁer in each article on global, grey
matter and white matter perfusion and blood ﬂow in
the major cerebral and carotid blood vessels. Next,
for each modiﬁer, the number of papers studying:
(1) global (including grey matter and white matter) per-
fusion; (2) regional perfusion and (3) other (major cere-
bral and carotid blood vessels) was attributed. Finally,
an eﬀort was made to analyze both global (including
grey matter and white matter) and regional eﬀect sizes
on brain perfusion. Global eﬀects refer to changes in
whole-brain perfusion. Regional eﬀects refer to changes
in the perfusion pattern of brain regions. The highest
eﬀect size was determined for each modiﬁer.
Using the three modiﬁer criteria, an ordinal classiﬁ-
cation was devised and each factor was assigned a com-
posite score consisting of a letter for quality – according
to the methodology presented in Figure 1 – and a
number for magnitude. The alphabetical order of letters
reﬂects the number of studies in which the reported
factor is mentioned (i.e. prevalence) as well as the
consistency of the corresponding inﬂuence on brain
perfusion (i.e. increase, decrease, no eﬀect): (a) ‘high
prevalence, consistent across studies’, (b) ‘high preva-
lence, inconsistent across studies’, (c) ‘low prevalence’.
The numbers represent the reported magnitude of
each perfusion-modiﬁer eﬀect: (1) ‘large eﬀects’,
(2) ‘intermediate eﬀects’, (3) ‘small eﬀects’, (4) ‘unknown’.
Supplementary Tables 1 to 5 summarize results of all
studies that were included in this review. Absolute
(in ml/100 g/min) and relative measurements of perfu-
sion in the brain were determined for each reported
factor. For global perfusion, the mean and range of
absolute and relative measurements reported across
studies were calculated. For regional eﬀects, only the
range of values presented in the literature was taken
into account. However, only studies including absolute
or relative values were selected for the section of results
of this review; studies with no such quantiﬁcation infor-
mation were only reported in the Supplementary
Tables.
Based on these ﬁndings, we propose a suggestion – in
the form of a standard operating procedure – to reduce
the eﬀect of physiological ﬂuctuations on ASL and
Table 2. Summary of non-medication related perfusion-modifiers found in the literature, classified into four groups, including the
number of studies presented in the Supplementary tables.
Physiology, lifestyle and health Blood components
Mental state, personality
and cognition
Caffeine and recreational
drugs
Age Blood gases: O2 Stress Caffeine
Occupation Blood gases: CO2 Anxiety Energy drinks
Social environment Hematocrit Yoga & meditation Nicotine
Gender Blood viscosity Mood Alcohol
Menstrual cycle Hemoglobin Cognitive capacity Recreational opioids
Pregnancy Fibrinogen Creativity Amphetamines
Menopause Blood glucose Personality Cocaine
Diurnal rhythm Homocysteine Sleep Cannabis
BMI Cholesterol Drowsiness/sleepiness Solvents and inhalants
Physical exercise / training Ketone bodies Open/closed eyes MDMA and LSD
Altitude ADMA Mental activity Psilocybin
Diving Free fatty acids Arousal and vigilance
Blood pressure
Heart rate
Body temperature
Mobile phone
Nutritional diet
Hunger/satiety
Fat intake
Sugar intake
Thirst
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other perfusion measures, and to acquire physiological
and cognitive data in a structured manner at the time of
perfusion assessment. The standard operating proced-
ure was constructed on the basis of procedures already
used in four research centers associated with the
European Cooperation in Science and Technology–
Arterial spin labelling Initiative in Dementia (COST–
AID Action BM1103).
Results
One hundred thirty-seven individual search terms were
used in combination with ‘cerebral blood ﬂow’ and
‘cerebral perfusion’. After screening and assessing for
eligibility, 553 full-text articles were included in the ana-
lysis of the eﬀects of modiﬁers on cerebral perfusion
(Supplementary Tables 1 to 5); 137 of which were
selected to summarize the modiﬁers’ eﬀects in this sec-
tion. All modiﬁers inﬂuencing global cerebral perfusion
were identiﬁed and are summarized in Figure 2. Fifty-
six human brain perfusion modiﬁers not related to
medication use – except for recreational drugs – are
summarized in Table 2. Table 3 categorizes the modi-
ﬁers according to the corresponding level of prevalence,
consistency and eﬀect size. The spread of all reported
quantitative absolute and relative information on the
eﬀects of the A1-modiﬁers, as well as the mean eﬀect
can be found in Figures 3 (absolute) and 4 (relative).
Physiology, lifestyle and health
Without any correction for GM volume changes, global
perfusion was found to be negatively associated with
age (A1), with an average decline of 0.27ml/100 g/min
(range 0.16 to 0.38) per year [0.53% (range
0.37% to 0.66%)].5 A decrease of 0.31ml/100g/min
(range 0.11 to 0.62) per year [0.49% (range
0.16% to 0.77%)] was reported in the gray
matter,12 in combination with a redistribution of CBF
among almost all cerebral regions. The eﬀect of age
only appeared to be signiﬁcant in adults after the ﬁfth
decade of life.5 The reported eﬀect on age-related
decrease in brain perfusion from corrections for contri-
bution of brain volume loss and partial volume is some-
what controversial. One study found no impact of age
on perfusion after correction for partial volume
eﬀects,13 whereas other similar studies have found an
age-related decline.5,14 In any case, age has to be taken
into account in any comparison of brain perfusion,
hence the A1 score. In children (A1) over ﬁve years,
age was found to be negatively correlated with grey
matter perfusion, causing an even more pronounced
decrease of 1.69ml/100 g/min (range 1.05 to
2.00) per year [1.92% (range 1.20 to 2.06)].15
The maximum global brain perfusion was found to be
reached at the age of 5 to 6.5 years.16 After reaching the
age of retirement (C2), continuing to work or partici-
pating in regular physical activities seemed to delay the
decline in perfusion.7 No association was found
between global cerebral perfusion and social environ-
ment (C3) in a single study comparing elderly subjects
living in their own home with those staying in a retire-
ment home or a hospital.17
Global perfusion in women was found to be
approximately 7.26ml/100 g/min (range 3.80 to 10.73)
higher [12.1% (11.0% to 21.9%)] than in men. There
are also regional increases in the frontal, temporal, par-
ietal and cingulate regions and in the basal ganglia.5,18
Nonetheless, gender-related diﬀerences in global and
regional perfusion were not reported in all studies.5
Actually, the gender (B1) eﬀect on cerebral perfusion
may be explained by the well-known gender diﬀerence
Figure 1. Schematic representation of the methodology applied to devise an ordinal classification of perfusion-modifiers based on
the three modifier criteria.
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in the hematocrit.19 The interaction between gender
and age is not yet solved and some contradictory obser-
vations have been reported. One study reported a
gender diﬀerence in perfusion in subjects older than
50 years,5 whereas other studies reported diﬀerences
starting during female reproductive years.20 Some
studies report that the age-related decline was
slower in women,14 while other studies found no
gender diﬀerence.21 The eﬀect of gender is therefore
important, but more work is needed for further
clariﬁcation.
Changes in blood ﬂow velocity in the middle cerebral
arteries have been observed during the menstrual cycle
(C3),22,23 but no eﬀects on gray matter perfusion were
found.24 During pregnancy (C4), a decrease in blood
velocity of the middle cerebral artery (MCAv) at a rate
Figure 2. Effects of modifiers on global brain perfusion summarized as a color gradient: factors in the green area induce no effect,
the blue and red areas represent global decrease and increase respectively. All factors are classified both according to their effect and
the corresponding magnitude on global perfusion changes. Other factors, whose value is still unknown, are grouped around the grey
rectangle.
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of decline of 0.59 cm/s (range 0.41 to 0.77) per week
[0.58% (range 0.57% to 0.58%)] has been
reported.25 Two studies investigated the eﬀect of meno-
pause (C4) on perfusion, which was found to decrease
in several regions.26 This eﬀect appears not to be asso-
ciated with age, nor with the elapsed time after
menopause.26
Global eﬀects of diurnal rhythm (C4) have not yet
been reported, but regional decreases seem to occur in
regions of the default mode network throughout the
day.27 One study observed a cosine course in the
MCAv.28
The eﬀect of body mass index (C3) on cerebral
blood ﬂow is inconclusive. Cerebral blood ﬂow vel-
ocity (MCAv) was found to be moderately decreased
in conjunction with an increase of body weight.29
Positive correlations between the fat-free body mass
(C4) and regional perfusion have been observed else-
where,30and a lowered global and regional perfusion
in overweight (C4) subjects has also been reported.31
Figure 3. Absolute effects of A1- and A2-modifiers on cerebral perfusion: absolute quantitative information for global (G), grey
matter (GM) and white matter (WM) reported in each study was plotted for each A1- and A2-modifier and the mean is visualized.
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Studies dealing speciﬁcally with obesity (BMI> 30)
and eating disorders (e.g. anorexia nervosa) are not
presented, as these are considered non-healthy
conditions.
Studies on the short-term eﬀects of physical exercise
(A1) reported strong and rather congruent eﬀects on
cerebral perfusion. Global perfusion was shown to be
increased by approximately 10.5ml/100 g/min (range
11.4 to 14.7) [22.1% (24.7 to 28.0%), and a regional
redistribution of ﬂow was generated. Thirteen minutes
after cessation of activity, global perfusion returned to
normal, even when the regional perfusion in the sen-
sorimotor area was still increased.32 Although other
studies did not report any eﬀect of exercise on global
perfusion,33 this apparent discrepancy can be (partially)
explained by changes in the partial arterial pressure of
carbon dioxide (PaCO2).
32–34 Perfusion changes are
also dependent on the load and type of exercise.34,35
After exercise (B1), some studies reported an increased
global perfusion,36 whereas other studies only reported
Figure 4. Relative effects of A1- and A2-modifiers on cerebral perfusion: relative quantitative information for global (G), grey matter
(GM) and white matter (WM) reported in each paper was plotted for each A1- and A2-modifier and the mean is visualized.
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regional changes with no eﬀects on global perfusion.37
The chronic eﬀects of long-term physical exercise or
training (B1) are rather incongruent.6,38 Curiously,
the diﬀerence in trained and sedentary men accounted
for a diﬀerence in MCAv equivalent ‘age’ of approxi-
mately 10 years.6 Regional redistributions have also
been observed,39 as well as associations between aer-
obic or cardiorespiratory ﬁtness due to an active life-
style (B1) and increased perfusion in the hippocampus
and grey matter.40 Regional perfusion appears to be
decreased down to 39ml/100 g/min (57,2%) after a
10-day cessation of physical training (C1) in master
athletes.41
Pressure changes by changing altitude (C1) have
profound eﬀects on brain perfusion. Climbing to high
altitude (i.e. about 4000m) increases global perfusion
by 9.65ml/100 g/min (range 9.10 to 10.2) [þ30.1%
(range 24.0 to 36.2)] during the ﬁrst day. The increase
is accompanied by regional redistributions.42
Approximately three weeks (C3) of acclimatization to
high altitude normalizes perfusion.43 Individual diﬀer-
ences in perfusion have been observed after descending
(C4) to lower altitude, following a long stay at high
altitude.44 In divers (C4), a decrease in both global
and regional perfusion was reported.45,46 In former
divers (C4), a persistent decrease of perfusion was
found in certain regions of the frontal lobe and in
parts of the cerebellum.47
The eﬀect of blood pressure has been extensively stu-
died. In chronic hypotension (C4) ([SBP]<100mmHg,
[DBP]<60mmHg), a decrease in the MCAv was
reported, while no changes in grey matter perfusion
were reported.48,49 Chronic hypertension (B1) (systolic
blood pressure (SBP)>150mmHg, diastolic blood pres-
sure (DBP)>90mm Hg) can decrease50 or increase
regional perfusion,51 which has been attributed to
gender-related diﬀerences in one study.52 A positive
relation between global brain perfusion and heart rate
(C4) was found, but perfusion in certain regions was
decreased.53
Hyperthermia and fever (C2) were also found to
decrease global perfusion at an average of 5.21ml/
100 g/min (range 2.72 to 7.70) [10.2% (range
5.48% to 15.0%)].54 Nevertheless, hyperthermia
was found to change the regional pattern of CBF by
increases in the frontal and temporal regions, and by
decreases in the limbic system, parietal lobe, and in the
cingulate cortex.55 These perfusion changes persisted
for at least 15min after normalization of body
temperature.55
Using a mobile phone (C4) appeared to change the
regional task-related brain perfusion pattern, but not
regional perfusion during rest.56 Perfusion increased
in the prefrontal region for at least 30min after using
the mobile phone.57 Having a cell phone by your side
during the so-called ‘resting’ state appears to induce no
changes on MCAv.58
Food and liquid intake has reported eﬀects on per-
fusion, but the eﬀects are not suﬃciently documented.
Dietary eﬀects were studied in only two reports where a
high nitrate diet (C4) was reported to increase perfusion
in several regions,59 whereas fasting during the
Ramadan (C4) induced no changes on MCAv.60
Satiety (B4) after eating was found to immediately
aﬀect regional perfusion.61 Fat intake (C3) induced a
decrease of nearly 13% in the perfusion of the hypo-
thalamus, and an increase of perfusion in the frontal
operculum, approximately half an hour after food
intake.62,63 Glucose and fructose (C4) seemed to exert
a distinct eﬀect on regional perfusion 15 to 60min after
intake. Fructose induced both regional increases and
decreases, whereas the eﬀects of glucose were limited
to regional decreases.64 Eﬀects on global perfusion
were not observed.65
The experience of thirst (B4) was found to redistrib-
ute regional perfusion, leading to increased perfusion in
several cortical (e.g. cingulate) and cerebellar areas, and
to decreased perfusion in the frontal and temporal
regions (e.g. hippocampus), the basal ganglia and the
midbrain.66 Satiety (B4) after drinking water was found
to redistribute perfusion in multiple cerebral regions.66
Blood composition and components
Blood gases, O2 and CO2, have a profound eﬀect on
brain perfusion.67 Hypoxia (B2) appears to increase
global perfusion at an average of 0.43ml/100 g/min
(range 0.26 to 0.59) per mmHg [þ0.87% (0.44% to
1.30%)] of decrease in the partial arterial pressure of
oxygen (PaO2).
68 The same was seen with hypercapnia
(A1) at an average of 1.65ml/100 g/min (range 0.80 to
2.89) per mmHg [þ3.95% (range 0.95% to 8.99%)] of
increase (PaCO2). These changes are associated with a
regional redistribution of perfusion.69 Hypocapnia (A1)
decreases both global and regional perfusion at a simi-
lar rate of change.70 However, it should be noted that
such a linear relationship was just observed in the range
of 23 to 60mmHg of PaCO2.
71 In some studies, hyper-
oxia (B1) appears to decrease both global and regional
perfusion; other studies report no eﬀects on global per-
fusion and an inverse eﬀect on regional
perfusion.72,73Again, an interaction was found between
the eﬀects of O2 and CO2.
67
A high hematocrit (B1) leads to a decrease in global
perfusion at an average of 0.73ml/100 g/min (range
0.32 to 1.55) [2.28% (range 0.64 to 3.50)] per
1% of increase in the hematocrit value.74 However, the
eﬀects of blood viscosity (C4) and hemoglobin (C2) are
still debatable. There are studies on blood viscosity
reporting no eﬀect on grey matter perfusion,
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accompanied by regional increases.75 The hemoglobin
value was observed to determine a decrease in global
perfusion at an average of 1.65ml/100 g/min per g/dl
of increase in the hemoglobin value, and to change
cerebral perfusion in certain brain regions.76,77 For
ﬁbrinogen (C2), a decrease in global perfusion of
3.20ml/100 g/min (6.43%) was found.78
For a blood glucose (B3) level below 3.6mmol/L
corresponding to severe hypoglycemia, both increases
and decreases in global perfusion were found, accom-
panied with increases of regional perfusion.79 Global
hyperperfusion was reported to outlast normalization
of blood glucose levels by 90min.79 However informa-
tion about the eﬀects of physiological blood glucose
level on brain perfusion was not found. Circulating
homocysteine (C1) levels were found to be associated
with a decrease in global perfusion (2.38ml/100 g/min/
mmol/L on average) and to induce some regional redis-
tribution.80 A heightened total cholesterol level (C4)
was found to decrease regional perfusion in the tem-
poral and parietal regions.81 Hyperketonemia (C1) – a
state that can occur in cachectic patients, but is unlikely
to be found in normal subjects – was reported to
increase global perfusion,82 which tends to normalize
after three days (C3).82 The results on the eﬀects of
asymmetric dimethylarginine (ADMA) (C3) are contra-
dictory, as either no eﬀect80 or a weak regional decrease
in perfusion of the basal ganglia83 were observed. Free
fatty acids (C4) were found to be either positively or
negatively associated with the degree of perfusion in
several brain regions depending on the fatty acid
composition.84
Mental state, personality and cognition
Mental stress (C3) can increase regional perfusion in
the cerebellum, putamen, insula and in the anterior cin-
gulate cortex.85 Global increases appear to be non-sig-
niﬁcant, but individual diﬀerences have been observed
and led to the suggestion that an inverted-U eﬀect
might occur.85 Likewise, an inverted-U eﬀect on brain
perfusion can be caused by anxiety (B1). There are
reports of global and regional perfusion increases in
situations causing low to moderate anxiety levels
(C4), and perfusion decreases in moderate to high anx-
iety (C4) generating conditions.86 Practicing yoga and
meditation (C4) changes the brain state and is asso-
ciated with a regional redistribution of perfusion,
depending on the method of meditation and its induced
depth.87 However, the reported results were obtained in
experienced Buddhist meditators.
Another factor that can inﬂuence brain perfusion is
mood. Stimuli inducing sadness (B3) have been found
to increase global perfusion, with regional redistribu-
tions among almost all brain regions. Happiness (B3)
was reported to induce both increases and decreases in
regional perfusion.88 Other mood states, such as disgust
(C4), worry (C4) and anger (C4) also have been
reported to inﬂuence regional perfusion.89–91 The
impact of a few aspects of cognitive capacity was inves-
tigated in a limited number of studies. A high intelli-
gence quotient (IQ) (B4) was associated with increases
in grey matter and regional perfusion.92 Other cognition-
related factors appear to redistribute regional perfusion,
such as processing speed (C4), verbal ﬂuency (C4),
memory (C4) and executive functioning (C4).93,94 Both
short (C4)-95 and long-term cognitive training (B1)96
increase regional perfusion. Creativity (C4) was found
to increase perfusion in several frontal regions (e.g. the
gyrus rectus), and to decrease it in the precuneus.92,97
Personality is a multi-dimensional perfusion-modi-
ﬁer still under investigation with only a limited
number of papers investigating. Extraversion (A4)
was found to be associated with a diﬀerent pattern of
brain perfusion compared to introversion (A4).98
Regional perfusion was increased in association with
persistence (C4) or novelty-seeking (C4) behavior,
whereas psychoticism (C4), neuroticism (C4), harm
avoidance (C4), and reward dependence (C4) decrease
perfusion in certain regions of the brain.98
Although the eﬀect of sleep on perfusion is quite well
understood, some aspects still remain unclear. During
non-rapid eye movement (NREM) sleep (A1), cerebral
perfusion decreases globally at an average of 5.65ml/
100 g/min (range 3.60 to 11.4) [14.0% (range
7.05% to 18.63%)] along with regional redistribu-
tions relative to pre-sleep perfusion.99,100 Afterwards,
during rapid eye movement (REM) sleep (B1), there
is an increase in the grey matter perfusion above pre-
sleep perfusion levels.99,100 This rate of change is attrib-
utable to the depth of sleep across various sleep stages
and cycles.99,101 Falling asleep (C4) seems to increase
the MCAv.102 Waking up spontaneously (C2), even at
night, decreases perfusion globally (17.5%) and redis-
tributes regional perfusion.102 By contrast, being awa-
kened (C2) increases both global (þ5.70ml/100 g/min;
þ14.3%) and regional perfusion compared to stage 2
sleep perfusion level.103 No association between perfu-
sion and subjective sleepiness (C4) has been found, but
some positive and negative regional variations with
drowsiness (C4) were observed both in normal and
sleep-deprived subjects.104
Opening the eyes (C1) increases global perfusion.
Watching a constant or ﬂickering ﬂashing light or a
video during a perfusion scan increases occipital perfu-
sion by 24.4ml/100 g/min (þ50%).105 Mental activity
(C1) was found to redistribute regional perfusion,
(e.g. during self-referential tasks).106,107 Arousal and
vigilance (C3) due to a given task can also exert an
eﬀect on regional perfusion.108
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Caffeine and recreational drugs
Acute caﬀeine (A2) intake exerts a profound short-term
decrease in global perfusion of approximately 2.75ml/
100 g/min (range 2.40 to 3.10) [10.2% (range
5.10 to 18.9)] in regular caﬀeine users.9,109 This
decrease was reported to last for at least 75min.109
These short-term eﬀects seem to be more pronounced
in subjects taking a low daily dose of caﬀeine,9 and to
be very much dependent on perfusion levels prior to
caﬀeine intake.109 Long-term eﬀects of daily caﬀeine
intake on perfusion are still not completely understood.
It was suggested that perfusion tends to normalize in
chronic (C3) users, due to a downregulation of vascular
adenosine receptors.9,110 Gray matter perfusion was
found to increase in heavy coﬀee drinkers after 24 h
of withdrawal (C4),9,110 and to normalize after 14
days (C4).110 Caﬀeine-containing soft drinks and tea
were found to exert similar eﬀects on cerebral perfu-
sion.111,112 The acute consumption of caﬀeine contain-
ing energy drinks (C4) was found to be associated with
a decrease in the MCAv (7.90 cm/s or 11.7%).113
Long-term nicotine (B2) use was found to be asso-
ciated with an average decrease of 6.37ml/100 g/min
(range 1.50 to 11.1) in global brain perfusion
[9.16% (range (2.0 to 15.5)].8 Short-term eﬀects
of smoking (B2) (on global and regional perfusion)
are reported to diﬀer among individuals. Increased,
decreased and normal global brain perfusion have
been observed in subjects smoking their favorite cigar-
ette brand.114 These short-term regional eﬀects were no
longer visible after an abstinence period of 24 h (B2)
which seems to abolish these short-term eﬀects
on regional perfusion.115 Although a tendency towards
normalization has been detected, global decreased
brain perfusion persists even after nine years of abstin-
ence (C2) following a long-term use of nicotine.116
Caution is needed when interpreting perfusion meas-
urements after withdrawal, since both nicotine-contain-
ing and denicotinized replacement therapies appear
to aﬀect regional perfusion as well,117 and it has
been observed that perfusion is modulated by psycho-
tropic eﬀects caused by withdrawal related to
addiction.117
Chronic alcohol (B1) consumption induced an aver-
age decrease of 2.43 (range 1.85 > 3.00) ml/
100 g/min (7.46%) in global perfusion along with
widespread regional perfusion changes.118 An acute
alcohol (B1) intake induces dose-dependent short-
term increases in global and regional perfusion up to
8.58ml/100 g/min (þ12.7%), which lasts at least for 2 h
after consumption.119,120 Global perfusion in chronic
alcohol drinkers has been reported to decrease after
24 h of abstinence (C1).121 A longer period of abstin-
ence (B1) results in a grey matter increase and regional
redistributions.122
The long-term use of recreational opioids (C4) was
found to be associated with a decreased perfusion in
some regions of the brain.123 An acute intake (B4) of
recreational opioids was also reported to induce mul-
tiple short-term changes in regional perfusion.124
Abstinence (B4) in long-term users was found to
induce a decrease of global and a redistribution of
regional perfusion.11 However, withdrawal eﬀects
induced by naloxone were associated with a decrease
in regional perfusion as well.11 The long-term use of
amphetamines (B1) was reported in combination with
regional perfusion deﬁcits.125,126 Nonetheless, these
eﬀects were neither observed in all subjects nor were
they correlated with dose or duration of abuse.125,126
An acute intake (A2) of amphetamines was reported to
induce no eﬀects on grey matter perfusion, but changes
in the pattern of brain perfusion in regions related to
the reward circuit.127,128 Even after months of abstin-
ence (A4), global and regional perfusion were found to
be decreased relative to normal volunteers.129
The long-term use of cocaine (B4) appears to be
associated with regional decreases in brain perfusion.130
An acute cocaine intake (B1) was found to cause a
decrease in global perfusion accompanied by regional
redistributions with a range from 36.6% to
þ28.1%.131 Such a short-term eﬀect is dose-dependent
and lasts for approximately 40min.131 Brain perfusion
was reported to increase and decrease compared to con-
trol subjects in some regions after more than one year
of abstinence (C4), whereas global perfusion tends to
normalize.132 The long-term use of cannabis (B1) has
been described to decrease global perfusion and to
cause changes in regional perfusion.133 However, the
eﬀects were not reported to be signiﬁcant in all stu-
dies.134 An acute use of cannabis (A2) was found to
increase grey matter perfusion at an average of 5.29
(range 2.51 to 7.51) ml/100 g/min [8.14% (3.29 to
13.8%)] in combination with an altered pattern of
regional perfusion.135 Global and regional perfusion
changes persist after at least two months of abstinence
(B4).133
Long-term exposure to solvents and inhalants (B4),
such as industrial dyes and ethers, was in some studies
found to be associated with a decrease in grey matter
perfusion.136 There are also changes in regional perfu-
sion, which is increased in the left occipital region and
decreased in the prefrontal and temporal cortices, and
in the thalamus.137 Acute inhalation (C1) appears to
regionally increase grey matter perfusion up to
14.2ml/100 g/min (þ20.9%).138 A couple of weeks
after an acute intake of 3,4-methylenedioxy-metham-
phetamine (MDMA) (C1), regional perfusion has
been reported to show a maximal decrease of
5.30ml/100 g/min (10.0%).139 Some months after
(C3) an acute intake, global perfusion appears also to
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decrease (2.30% on average).139 Somewhat surpris-
ingly, LSD (C4) was not found to have any eﬀect on
global brain perfusion, but the eﬀects of this modiﬁer
should be further investigated as more information is
lacking.140 An acute psilocybin (hallucinogenic mush-
rooms) (C4) intake was reported to be associated with
regional decreases.141Finally, the eﬀects of many other
recreational drugs have not yet been studied.
Discussion
This literature review shows that the most relevant fac-
tors inﬂuencing perfusion of the brain (ranked as A1)
are age (adult), age (children), physical exercise
(during), hypercapnia, hypocapnia and NREM sleep.
Given that it is not always possible to correct for
these modiﬁers at the time of perfusion assessment,
especially in the clinical setting, their eﬀects should be
taken into account during the interpretation of perfu-
sion images and quantiﬁcation. Although the variabil-
ity of reported results is often quite large for many
factors classiﬁed in category B, some perfusion-modi-
ﬁers belonging to category A also deserve further
research due to pronounced variability across study
results (e.g. in quantitative information) or the insuﬃ-
cient available information (e.g., on the dynamics of the
eﬀects). Furthermore, a large group of potential modi-
ﬁers in category C needs investigation to ascertain the
corresponding eﬀects on cerebral perfusion. In order to
correct for the eﬀects of all perfusion-modiﬁers, it is
crucial to adopt a standard operating procedure in
the research setting. In the clinical setting such a pro-
cedure is also recommendable, at least to account for
the eﬀect of perfusion-modiﬁers categorized as A1.
Understanding the effects of perfusion-modifiers
Regional and global perfusion alterations, caused by
the described perfusion modiﬁers, can mimic similar
regional disease-related changes which might be of the
same order of magnitude. More so, in early or mild
stages of neurodegeneration and psychiatric disorders,
perfusion changes will be subtle and in line with
changes caused by non-disease-related perfusion modi-
ﬁers. For example, in patients with early-onset
Alzheimer’s Disease, a hypoperfusion in the precuneus
and posterior cingulate cortex has been reported,142 a
perfusion pattern that can also be observed in healthy
subjects after an acute intake of caﬀeine.112
From the review, it is also clear that the understand-
ing of certain perfusion-modiﬁers is still limited (e.g.
IQ, mood, cognition and education), incomplete (e.g.
smoking and chronic caﬀeine use), or even contradict-
ory (e.g. physical training and blood pressure). On top
of that, the eﬀect of some speciﬁc factors has not been
studied in healthy subjects at all. For instance, in spite
of the fact that signiﬁcant – yet inconsistent – eﬀects of
education143 and job complexity144 have been described
in perfusion studies involving patients with Alzheimer’s
disease, the same eﬀects have not yet been conﬁrmed in
healthy volunteers. Likewise, the eﬀect of some other
factors remains to be investigated, such as physical
exercise before a perfusion scan (e.g. a brisk walk or
bike ride to the scanning facility), ethnicity, loneliness,
handedness, hyperglycaemia and eating related factors
like long-term fasting, hunger and satiety. It is also
unclear how important genetic factors are for cerebral
perfusion.
Data acquisition, methods, and a standard operating
procedure for the assessment of brain perfusion
Surplus variation secondary to non-standardized acqui-
sition or post-processing complicates the interpretation
of perfusion imaging.145 Given that ASL images can be
acquired using many diﬀerent sequences and scanners,
and that there are many post-processing methods and
models for their analysis, a strategy to homogenize data
acquisition and post-processing methods must be estab-
lished. These issues – outside the scope of this review –
were thoroughly discussed in a recent paper by Alsop
et al,145 and should be kept in mind when interpreting
perfusion images or the eﬀects of perfusion-modiﬁers.
Additionally, extra standardization and knowledge
will help to reduce variance and create a scope for the
correct interpretation of perfusion measurement
results. The extensive procedure is summarized in
Table 4, and includes speciﬁc assessments, neuropsy-
chological testing, physiological measurements, scan
instructions, and a questionnaire. Some parameters
can be measured before or during the perfusion scan.
For instance, body weight, temperature and blood pres-
sure can easily be measured. Several blood components
(hematocrit, hemoglobin, homocysteine, caﬀeine con-
centration, nicotine concentration, alcohol concentra-
tion) can be determined by taking a blood sample.
Capnography can be used to calculate the end-tidal
CO2; heart and respiratory rate can be measured
using physiological monitoring systems during scan-
ning. Some of the perfusion modiﬁers can also be mod-
elled out if accurate theoretical models are available to
describe their eﬀects.
Speciﬁc instructions can be used to improve subject
cooperation and to reduce variability caused by the
scanner environment. Perfusion assessment at a ﬁxed
time of the day should minimize the eﬀects of diurnal
rhythm. Minimizing stress and anxiety can be achieved
by thoroughly explaining the experiment and character-
istics of the MRI environment to the volunteer before
the perfusion scan, and by using clear instructions
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during the scanning session as well. It is essential that
the volunteer feels comfortable and knowledgeable
about what to expect (e.g., loud noises). Restricting
the use of a mobile phone can be advised for a few
hours before the perfusion scan. However, the necessity
of this impractical restriction still has to be proved.
Asking the volunteer not to perform strenuous exercises
before scanning can be suggested, but this may be dif-
ﬁcult in certain situations (e.g. if the volunteer cycled to
the scanning facility or had to hurry to be on time). In
these circumstances, it might be wiser to take this modi-
ﬁer into consideration and, if possible, to allow for
some rest before measuring perfusion. Adequate hydra-
tion can be ascertained by instructions before scanning.
However, beware that drinking too much before scan-
ning might lead to a toilet break during the scan
session.
Asking the subjects to close their eyes and dimming
lights in the scanner room minimizes the eﬀects of light
and closed versus opened eyes during the perfusion
scan. It is important that the subject remains in a
‘resting state’ by simple instruction or message at the
beginning of perfusion scanning, just like it is done for
resting state fMRI. It is imperative that the subject
doesn’t sleep. The awake condition can be checked by
inquiring with the subject or by using EEG during the
perfusion scan. Asking the volunteers about their sleep
during the night before scanning might provide some
extra information on their predisposition to fall asleep.
Instructing the subjects not to move during the perfu-
sion scan is mandatory to avoid motion artefacts,
which always induces unwanted measures and quanti-
ﬁcation problems. Using rigorous procedures for pos-
itioning can also minimize unwanted movement.
The use of an adequate questionnaire and a set of
psychological tests can be helpful to assess the so-called
‘physiotype’ of the brain of a given subject.
Information on age, occupation, social environment,
gender, menstrual cycle, pregnancy and menopause
can be taken into account by using such a simple ques-
tionnaire. In spite of being unusual in clinical and
research settings, factors such as altitude and diving
can also be queried. It might be useful to take into
account the usual pattern of physical exercise and the
exercise practiced the day before and on the day of
scanning. Providing a standardized meal an hour
before the perfusion scan might minimize the eﬀects
of food on perfusion. However, this solution may not
take metabolism-related variability into account and
can be quite expensive and impractical. A better
option would be to query dietary habits and informa-
tion related to the last meal before the perfusion scan.
Table 4. Summary of the standard operating procedure proposed to reduce perfusion-modifiers induced variability.
Questionnaire (Q) Measurements (M) Neuropsychology (N) Instructions (I)
Age Thirst Diurnal rhythm Free fatty acids IQ Diurnal Rhythm
Occupation Stress Blood pressure Stress Cognitive capacity Physical exercise/
training
Social environment Anxiety Heart rate Anxiety Mobile phone
Gender Mood Body temperature Mood Hunger/Satiety
Menstrual cycle IQ Blood gasses: O2 Sleep Fat intake
Pregnancy Cognitive capacity Blood gasses: CO2 Drowsiness/
Sleepiness
Sugar intake
Menopause Creativity Hematocrit Arousal Thirst
BMI Personality Blood viscosity Caffeine
concentration
Sleep
Physical exercise/
training
Drowsiness/
sleepiness
Hemoglobin Nicotine
concentration
Drowsiness/
Sleepiness
Altitude Arousal Fibrinogen Alcohol
concentration
Open/closed eyes
Diving Caffeine Blood glucose Mental activity
Nutritional diet Energy drinks Homocysteine Caffeine
Hunger/satiety Nicotine Cholesterol Nicotine
Fat intake Alcohol Ketone bodies Alcohol
Sugar intake Recreational drugs ADMA Recreational drugs
Additional potential perfusion modifiers (not studied in literature/not included in review)
Educational level Pathology Respiratory rate Pathology Medication
Handedeness Medication
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Likewise, information on the current and past use of
caﬀeine (and other recreational drugs) can be easily
acquired by using a questionnaire. Advising withdrawal
of acute drug intake is a plausible option. However,
asking a volunteer not to smoke or drink or eat caﬀein-
ated foods (e.g. coﬀee, tea, coke, chocolate) for a
couple of hours before scanning can cause even more
variability in perfusion due to withdrawal eﬀects.
A better approach would be to determine how much
consumption of these drugs occurred the day before
and the day of scanning. Querying the subjective feeling
of thirst immediately after the perfusion scan may be a
practical solution to control for the eﬀects of thirst on
perfusion. Several aspects of cognitive capacity and cre-
ativity can be tested using a battery of neuropsycho-
logical tests. A personality test before scanning can
provide information regarding the personality of the
volunteer. Finally, a mood-sensing test should be per-
formed before the perfusion scan. A simple mood
rating can also be assessed immediately after scanning,
using a visual analogue scale for happy and sad mood.
The standard operating procedure proposed is the
result of a collaborative eﬀort of the European COST
– AID Action BM1103, and should be applied in the
setting of the recently published consensus on best
practices for ASL acquisition and post-processing.146
Although this standard operating procedure is mostly
applicable in the context of perfusion measurements
using ASL, it can be used as a normalisation system
to control for between- and within-subject variability
with other perfusion techniques as well. The standard
operating procedure is available as Supplementary
material.
Deep MRI physiotyping
Obtaining personalized proﬁles and perfusion data
from a large number of healthy subjects on the basis
of a standard operating procedure would provide an
opportunity to develop the so-called ‘deep MRI physio-
typing’. In other words, it would be possible to match a
given volunteer to a speciﬁc physiotypic proﬁle by using
perfusion data and personalized information. The most
diﬃcult challenge of ‘deep MRI physiotyping’ would be
obtaining a database large enough to create persona-
lized normality templates. A ﬁrst big challenge is the
number of templates and the amount of data to popu-
late the templates which, due to the multi-dimension-
ality of the problem with so many factors to take into
account, could well be over 10,000 datasets. Although
large databases of normal brain MRI already exist and
precautions have been taken to deal with unwanted
variance, most of these do not include knowledge
about the many perfusion-modiﬁers as appears to be
required.18
Another challenge is the lack of standardized neuro-
psychological testing and the diﬃculty to test all
domains of cognition. A consensus is needed on the
choice of neuropsychological tests in order to deﬁne a
speciﬁc physiotype. For instance, in the United States
of America (USA), the National Institute of Health
(NIH) toolbox sets an example of how neuropsych-
ology can be standardized.147 Unfortunately, this
framework is only validated in the USA for native
English and Spanish speakers, despite ongoing eﬀorts
to translate this into other languages and cultures,
including those of the European countries. In order to
test the most important major neuropsychological
domains and to rule out major psychiatric disorders,
it would be recommendable to choose a battery of
neuropsychological tests assessing general cognition,
memory, language, attention, verbal ﬂuency, processing
speed, executive function and visuospatial skills.
Limitations of this review
The major limitation of this review derives from the
existing variety of techniques andmethods used to inves-
tigate the reported perfusion-modiﬁers. Moreover, older
studies mostly focused only on perfusion-modiﬁers lead-
ing to an increase of cerebral perfusion (as opposed to a
decrease in perfusion), which may have introduced a
potential bias to this review. Furthermore, the concepts
of global and regional perfusion, as well as the assessed
cerebral regions were not precisely deﬁned in many stu-
dies. This complicates the interpretation and generaliz-
ability of the reported results.
There was no uniformity in the reported units to
measure perfusion. Results obtained on the basis of
macrovascular approaches, such as TCD and angiog-
raphy (Table 1), should also be interpreted with care,
as these techniques measure blood ﬂow velocity in a
large cerebral artery (e.g. in the ICA or the MCA),
rather than perfusion at the microvascular level.
Therefore, results only based on macrovascular data
were marked with an asterisk (*) in the supplementary
tables. Nevertheless, we assume that these techniques
can provide a strong indication of changes in blood
supply to the brain.3 For each modiﬁer, the average
value and range of the reported information are pre-
sented in the results section and the supplementary
tables. However, only a few papers reported quantitative
information, which complicates a correct attribution of
their eﬀect sizes. Additionally, the reported absolute
values of CBF have been found to widely vary between
30 and 99ml/100 g/min for grey matter, and between 13
and 45ml/100 g/min for white matter,148 which also pre-
cludes us from drawing uniform conclusions. Many stu-
dies mentioned either only absolute or only relative
values. Therefore, a scaling factor across average
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values (per modiﬁer) was impossible. It was also, obvi-
ously, impossible to present ranges for those modiﬁers
that were only investigated by a single study. For these
reasons, the use of averages and ranges reported in this
review cannot be used as a recommendation for use as
some kind of correction factor, but they can be inter-
preted as a way of understanding which modiﬁers have
the most signiﬁcant eﬀect size on perfusion.
Another limitation of this review pertains to the fact
that the reported eﬀects of some perfusion-modifying
factors were considered in isolation, because inter-
actions between modiﬁers were often not described.
A key example here is the inﬂuence of PaCO2 on per-
fusion, which probably depends on PaO2, and vice
versa.67 Another example is the above-mentioned inter-
action between the eﬀects of gender and hematocrit on
cerebral perfusion.19 In the future, interactions might
be better characterized using ‘deep MRI physiotyping’,
assuming that the necessary eﬀects are taken into
account. This review did not address the many under-
lying psychological and physiological mechanisms to
explain the eﬀects of modiﬁers. A better understanding
of these mechanisms could clarify some of the reported
results, but this was not the main goal of the current
report.
Results from some patient studies were included in
this review of modiﬁers of normal perfusion because
most knowledge for certain modiﬁers was obtained
from such studies, and the factors described are often
present in part in what is considered normal or in sub-
jects who present themselves as normal. This includes
studies about blood pressure, haematocrit, blood
viscosity, haemoglobin and LDL-cholesterol.
Furthermore, plenty of studies investigating the eﬀects
of alcohol and recreational drugs included patients
suﬀering from poly-drug dependency. Because of the
signiﬁcant role of the results of those studies in the
understanding of perfusion modiﬁers, exceptions for
inclusion have been made. Finally, the eﬀects of pre-
scription and over-the-counter drugs were not included
in this review. This can be regarded as an additional
limitation, as it is clear that many medicinal drugs have
a large inﬂuence on perfusion.10,11 Nevertheless, given
that we wanted to investigate perfusion-modiﬁers in
normal subjects and medication is related to patho-
logical conditions, we decided not to include the cor-
responding eﬀects in this review.
Conclusion
This review provides an overview of perfusion-modify-
ing factors inﬂuencing between- and within-subject
variability of perfusion measurements. It underlines
the complexity and importance of numerous inﬂuences
on brain perfusion that can aﬀect its quantiﬁcation
and pattern. The eﬀect of over ﬁfty perfusion-modiﬁers
was reported. In order to disentangle their impact from
eﬀects caused by disease, we suggest the combination of
a standard operating procedure with a novel approach
called ‘deep MRI physiotyping’. This approach can help
to create personalized perfusion templates and be an
invaluable resource to set up multi-center studies,
longitudinal studies, and to help validating clinical
applications of ASL. By extrapolation, it may also
be helpful to interpret other quantitative measures of
the brain.
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